Bacher, Ulrike

[["dc.bibliographiccitation.firstpage","2588"],["dc.bibliographiccitation.issue","10"],["dc.bibliographiccitation.journal","Leukemia & Lymphoma"],["dc.bibliographiccitation.lastpage","2590"],["dc.bibliographiccitation.volume","60"],["dc.contributor.author","Shumilov, Evgenii"],["dc.contributor.author","Flach, Johanna"],["dc.contributor.author","Joncourt, Raphael"],["dc.contributor.author","Porret, Naomi"],["dc.contributor.author","Wiedemann, Gertrud"],["dc.contributor.author","Novak, Urban"],["dc.contributor.author","Gfeller, Eva"],["dc.contributor.author","Jeker, Barbara"],["dc.contributor.author","Amstutz, Ursula"],["dc.contributor.author","Pabst, Thomas"],["dc.contributor.author","Bacher, Ulrike"],["dc.date.accessioned","2020-12-10T18:14:59Z"],["dc.date.available","2020-12-10T18:14:59Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1080/10428194.2019.1585838"],["dc.identifier.eissn","1029-2403"],["dc.identifier.issn","1042-8194"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/74693"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","319"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Hematological Oncology"],["dc.bibliographiccitation.lastpage","322"],["dc.bibliographiccitation.volume","37"],["dc.contributor.author","Shumilov, Evgenii"],["dc.contributor.author","Flach, Johanna"],["dc.contributor.author","Joncourt, Raphael"],["dc.contributor.author","Porret, Naomi"],["dc.contributor.author","Wiedemann, Gertrud"],["dc.contributor.author","Angelillo‐Scherrer, Anne"],["dc.contributor.author","Trümper, Lorenz"],["dc.contributor.author","Fiedler, Martin"],["dc.contributor.author","Jeker, Barbara"],["dc.contributor.author","Amstutz, Ursula"],["dc.contributor.author","Pabst, Thomas"],["dc.contributor.author","Bacher, Ulrike"],["dc.date.accessioned","2020-12-10T14:06:37Z"],["dc.date.available","2020-12-10T14:06:37Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1002/hon.v37.3"],["dc.identifier.eissn","1099-1069"],["dc.identifier.issn","0278-0232"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/69965"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]